Literature DB >> 17462540

Coenzyme Q and protein/lipid oxidation in a BSE-infected transgenic mouse model.

Sergio F Martin1, Isabel Burón, Juan C Espinosa, Joaquín Castilla, José M Villalba, Juan M Torres.   

Abstract

Oxidative stress and antioxidants play an important role in neurodegenerative diseases. However, the exact participation of antioxidants in the evolution of prion diseases is still largely unknown. The aim of this study was to assess brain levels of coenzyme Q (CoQ), an endogenous lipophilic antioxidant, and the antioxidant/pro-oxidant status by determining oxidative damage to proteins and lipids after intracerebral bovine spongiform encephalopathy (BSE) infection of transgenic mice expressing bovine prion protein (PrP). Our results indicate that, whereas the ratio between the two CoQ homologues present in mice (CoQ(9) and CoQ(10)) is not altered by prion infection during the course of the disease, significant increases in total CoQ(9) and CoQ(10) were observed in BSE-infected mice 150 days after inoculation. This time point coincided with the first manifestation of PrP(Sc) deposition in nervous tissue. In addition, CoQ(9) and CoQ(10) levels, neuropathological alterations, and PrP(Sc) deposition in nervous tissues underwent further increases as the illness progressed. Lipid and protein oxidation were observed only at the final stage of the disease after clinical signs had appeared. These findings indicate upregulation of CoQ(9)- and CoQ(10)-dependent antioxidant systems in response to the increased oxidative stress induced by prion infection in nervous tissue. However, the induction of these endogenous antioxidant systems seems to be insufficient to prevent the development of the illness.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17462540     DOI: 10.1016/j.freeradbiomed.2007.03.005

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  7 in total

Review 1.  CoQ10 a super-vitamin: review on application and biosynthesis.

Authors:  Shraddha Shukla; Kashyap Kumar Dubey
Journal:  3 Biotech       Date:  2018-05-09       Impact factor: 2.406

Review 2.  Recent advances in prion chemotherapeutics.

Authors:  Valerie L Sim; Byron Caughey
Journal:  Infect Disord Drug Targets       Date:  2009-02

3.  Methionine oxidation perturbs the structural core of the prion protein and suggests a generic misfolding pathway.

Authors:  Nadine D Younan; Rebecca C Nadal; Paul Davies; David R Brown; John H Viles
Journal:  J Biol Chem       Date:  2012-05-31       Impact factor: 5.157

4.  Central nervous system gene expression changes in a transgenic mouse model for bovine spongiform encephalopathy.

Authors:  Raül Tortosa; Xavier Castells; Enric Vidal; Carme Costa; María del Carmen Ruiz de Villa; Alex Sánchez; Anna Barceló; Juan María Torres; Martí Pumarola; Joaquín Ariño
Journal:  Vet Res       Date:  2011-10-28       Impact factor: 3.683

5.  Antioxidant Effect of Coenzyme Q10 in the Prevention of Oxidative Stress in Arsenic-Treated CHO-K1 Cells and Possible Participation of Zinc as a Pro-Oxidant Agent.

Authors:  Saulo Victor E Silva; María Celeste Gallia; Jefferson Romáryo Duarte da Luz; Adriana Augusto de Rezende; Guillermina Azucena Bongiovanni; Gabriel Araujo-Silva; Maria das Graças Almeida
Journal:  Nutrients       Date:  2022-08-10       Impact factor: 6.706

6.  Effect of Treating Eggs with Coenzyme Q10 (CoQ10) on Growth Variables, Histomorphometry, and Antioxidant Capacity in Red Tilapia (Oreochromis aureus × Oreochromis mossambicus) Larvae.

Authors:  Mona M Mourad; Shimaa A Shahin; Ibrahim T El-Ratel; Mohammed F El Basuini
Journal:  Animals (Basel)       Date:  2022-08-29       Impact factor: 3.231

Review 7.  p62-Keap1-NRF2-ARE Pathway: A Contentious Player for Selective Targeting of Autophagy, Oxidative Stress and Mitochondrial Dysfunction in Prion Diseases.

Authors:  Syed Zahid Ali Shah; Deming Zhao; Tariq Hussain; Naveed Sabir; Mazhar Hussain Mangi; Lifeng Yang
Journal:  Front Mol Neurosci       Date:  2018-10-04       Impact factor: 5.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.